CoChat

Double‐blind placebo‐controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism

Merza, Z., Blumsohn, A., Mah, P. M., Meads, D. M., McKenna, S. P., Wylie, K., Eastell, R., Wu, F., Ross, R. J. M. · 2006 · International Journal of Andrology
Cited by 55

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Summary: Clinical studies suggest there may be a threshold concentration of serum testosterone below which replacement will result in skeletal and psychological benefit. We evaluated the response to testosterone in men with borderline hypogonadism. A randomized double‐blind placebo‐controlled trial in 39 men over age 40 years presenting with sexual dysfunction and a borderline low testosterone level (total testosterone <10 nmol/L or free androgen index <30%). Patients were randomized to Testoderm®TTS body patch (5 mg/day, n = 20) or a placebo patch (n = 19) for 6 months, followed by open‐label testosterone replacement for a further 6 months in all patients. During the placebo‐controlled phase of the study serum testosterone increased significantly on testosterone vs. placebo treatment (p = 0.004); this was associated with a decrease in total body fat mass (p = 0.019) and increase in haemoglobin level (p = 0.036). There were no significant changes in lean body mass, markers of bone turnover, and measures of bone mineral density (BMD). There was evidence of difference in quality of life according to the Male Erectile Dysfunction Quality of Life questionnaire (MEDQoL score, p = 0.017), mainly accounted for by deterioration in the placebo arm. When the active treatment period was combined for placebo and testosterone groups, the within‐patient analysis showed a significant effect of testosterone to decrease markers of bone resorption (uNTX/Cr, p = 0.007; iFDPD/Cr, p = 0.0006) and to increase lean body mass (p = 0.001). There was little convincing evidence from this study that testosterone replacement is likely to have major benefit in men over age 40 years with borderline hypogonadism and sexual dysfunction. However, there was evidence of suppression in bone resorption and hence longer and larger studies are needed to examine its effect on BMD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2605.2005.00612.x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 55

Metadata

Authors
Merza, Z., Blumsohn, A., Mah, P. M., Meads, D. M., McKenna, S. P., Wylie, K., Eastell, R., Wu, F., & Ross, R. J. M.
Venue
International Journal of Andrology
Publisher
Wiley
Published
2005-12-22
Volume
29
Issue
3
Pages
381-391
ISSN
  • 0105-6263 (ISSN-L)
  • 1365-2605
OpenAlex
W2119276674
Cited by
55
References
16
FWCI
0.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Double‐blind placebo‐controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. https://app.cochat.ai/papers/10.1111/j.1365-2605.2005.00612.x
The paper
Merza, Z., Blumsohn, A., Mah, P. M., Meads, D. M., McKenna, S. P., Wylie, K., Eastell, R., Wu, F., & Ross, R. J. M. (2006). Double‐blind placebo‐controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. International Journal of Andrology. https://doi.org/10.1111/j.1365-2605.2005.00612.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.